Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

AM2201 6-hydroxyindole metabolite

  • Zoom
    AM2201 6-<wbr/>hydroxyindole metabolite
  • AM2201 6-<wbr/>hydroxyindole metabolite
Cat No: 11192
Biochemicals - Drugs Of Abuse
Cayman
€125.00
Price is excluding VAT and does not include packaging neither shipping

AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the central CB1 and peripheral CB2 receptors, respectively.{18696} AM2201 6-hydroxyindole metabolite is an expected metabolite of AM2201 generated during phase I metabol...

More

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Pharma only in Europe
Synonyms:
  • (1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)methanone
Correlated keywords:
  • cannabinoids CBs CB1 CB2 receptors pain forensic science neuroscience metabolites AM-2201 AM 2201 synthetic central peripheral P450 P-450 cytochromes blood urine analytical 2201am references standards
Product Overview:
AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the central CB1 and peripheral CB2 receptors, respectively.{18696} AM2201 6-hydroxyindole metabolite is an expected metabolite of AM2201 generated during phase I metabolism by cytochrome P450, suggesting that it would be detectable in blood and urine.{19353} The biological properties of this compound are not known. This product is intended for forensic applications.
Size 1 mg
Shipping dry ice
Stability Store at -20 degrees; shelf life 730 days
CAS Number 1427521-35-4
Molecular Formula C24H22FNO2
SMILES O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CCCCCF)C4=CC(O)=CC=C43
Molecular Weight 375,4
Formulation A crystalline solid
Purity ≥98%
Custom Code 2933.49
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : AM2201 6-<wbr/>hydroxyindole metabolite There are 10 products.

Search